Suja Life (SUJA) Q1 2026 earnings review
A Spectacular Public Debut Marred Only by Sandbagged Guidance
Suja Life crushed its first earnings report as a public company. Revenue surged 22.5% year-over-year to $107.1 million, but the real story is operational leverage. The company reversed its bottom-line trajectory, turning a year-ago loss into a $7.7 million net income, while Adjusted EBITDA skyrocketed 66.3%. Gross margins expanded thanks to better mix and production scale. However, the FY26 guidance paints a vastly different, decelerating picture for the rest of the year, suggesting management is either heavily sandbagging or anticipating a massive drop-off in volume.
🐂 Bull Case
SG&A expenses plummeted from 41.3% to 35.3% of net sales, dropping straight to the bottom line and driving a 66% surge in Adjusted EBITDA.
The company used $173.6 million in IPO proceeds to aggressively pay down debt, reducing its term loan to $164.9 million. This will significantly reduce the $7.5 million quarterly interest burden moving forward.
🐻 Bear Case
FY26 guidance of $367-$371 million implies flat-to-negative sequential revenue for the remaining three quarters compared to Q1's $107.1 million actuals.
Despite slashing marketing in the Emerging Brands segment, overall SG&A dollars still rose 5% largely due to escalating freight expenses.
⚖️ Verdict: 🟢
Bullish. The core business is firing on all cylinders with phenomenal margin expansion and volume growth. While guidance implies deceleration, it is highly likely the new public management team is setting a low bar to easily beat in coming quarters.
Key Themes
Product Mix Shifts Drive Gross Margin Expansion
Gross margin expanded 70 basis points to 50.5%. Management explicitly cited a favorable product mix shift toward higher-margin wellness shots and multi-packs. This proves that product innovation is directly translating to enhanced unit economics, offsetting macro supply chain pressures.
Emerging Brands Serving as Growth Engine
While Suja Core provides the base (+21.4%), the Emerging Brands segment is accelerating rapidly, posting 40.3% YoY growth to $3.0M. The growth came via distribution gains and improved consumer takeaway, proving Suja's platform can successfully incubate and scale newer product lines.
Massive SG&A Leverage
The company's scale is finally paying off. SG&A fell from 41.3% of sales in 25Q1 to 35.3% in 26Q1. This 600-basis-point operational improvement is the primary driver behind Adjusted EBITDA margin jumping from 17.2% to 23.4%.
Guidance Contradicts Q1 Momentum
A massive red flag in the narrative: Q1 delivered $107.1M in revenue and $25.0M in Adj. EBITDA. Yet, FY26 guidance is set at $369M revenue and $71M Adj. EBITDA (midpoints). This means the remaining three quarters will average just $87.3M in revenue and $15.3M in EBITDA. Either Q1 benefited from severe pull-forward/favorable shipment timing, or management is aggressively sandbagging.
Macro Impact: Freight Costs Biting
Despite a conscious reduction in marketing spend for the Emerging Brands segment, total SG&A expenses still rose 5.0% year-over-year. Management pinned this increase squarely on rising freight expenses. If fuel and logistics costs accelerate further, it could threaten the company's newfound operating leverage.
Lingering Debt and Interest Burden
Suja Life used IPO proceeds to aggressively pay down debt, bringing the term loan down to $164.9M. However, they are still guiding for $19.0M in net interest expense for FY26. While better than Q1's $7.5M run-rate, it remains a meaningful drag on cash flow for a company that generated $6.1M in operating cash this quarter.
Other KPIs
Accelerating. Up 21.4% year-over-year from $86.4M. This segment represents 98% of total revenue and is seeing balanced strength across both wellness shots and core juices. The growth was volume-driven, which is much higher quality than price-driven growth.
Expanding. Up 70 basis points from 49.8% a year ago. Driven by better overhead absorption from higher production volumes, production efficiencies, and a higher-margin product mix.
Reversing. Turned positive from a $3.8 million outflow in 25Q1, driven entirely by the swing to net profitability and disciplined working capital management, despite a $3.2M headwind from inventory builds.
Guidance
Decelerating. Implies 12.4% to 13.6% growth over FY25's $326.6M. Given Q1 just printed 22.5% growth, achieving this guidance requires revenue growth to significantly decelerate in the final three quarters of the year.
Decelerating sequentially. While this represents massive 72.8% to 77.7% growth over FY25's $40.5M, Q1 alone already delivered $25.0M (35% of the full-year midpoint). This implies run-rate profitability will shrink materially for the rest of the year.
Stable post-IPO. Reflects the new run-rate after paying down the term loan from $303.5M to $164.9M following the public offering.
Key Questions
The Guidance Disconnect
Q1 revenue was $107M, but FY guidance implies the remaining quarters will average just $87M. Is Q1 highly seasonal for the beverage category, did shipment timing pull forward significant revenue, or is guidance simply conservative for your first public quarter?
Freight Cost Trajectory
Freight was called out as a specific headwind to SG&A this quarter. Are you currently seeing relief in logistics rates, or should investors expect freight to remain a drag on operating leverage for the rest of 2026?
Emerging Brands Investment
You noted a decrease in marketing spend for the Emerging Brands segment, yet it still grew 40%. Is this reduced spend a permanent strategic shift toward organic/distribution-led growth, or a temporary timing difference?